TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Safety and Immunogenicity of a Fourth Dose of Omicron BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18-55 Years Old.

Patricia Winokur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.